• PO Box 450 Mawson ACT, 2607 Australia

  • 02 6260 4022

Tech alert: TGA consultation mecobalamin- Dual name labelling transition to sole ingredient names

08 Nov 2022 12:57 PM | Anonymous member (Administrator)

The TGA has released a public consultation, closing 19 December 2022, seeking views on whether the dual naming of certain ingredients should end on 30 April 2023.

In relation to listed complementary medicines, only sponsors of medicines containing mecobalamin (comethylcobalamin) are affected. 

This technical alert provides information for affected sponsors of mecobalamin (comethylcobalamin), including CMA’s draft position and details on how to respond to the consultation.

Copyright © 2019 Complementary Medicines Australia. All rights reserved.

Powered by Wild Apricot Membership Software